Press Room

Avion and Acella Pharmaceuticals Provide Statement Related to Avondale Drug Pricing News14-Dec-2017

ATLANTA – (Dec. 13, 2017) – Avion pharmaceuticals, LLC, and their partner company, Acella Pharmaceuticals recently responded to the r..

Acella Pharmaceuticals Signs Product Development Agreement with Catalent To Bring Opioid-Abuse Deter11-Aug-2017

ATLANTA – (Aug. 10, 2017) – Acella Pharmaceuticals, LLC, a leading U.S. manufacturer of specialty pharmaceuticals across several ther..

Acella Pharmaceuticals, LLC, announces approval of generic to VituzĀ® Oral Solution27-Jul-2017

ATLANTA (July 27, 2017) - Acella Pharmaceuticals, LLC, a leading U.S. developer of specialty pharmaceuticals across several therapeutic categorie..

Acella Pharmaceuticals, LLC, announces approval of a generic Bromfed antihistamine/decongestant07-Nov-2016

ATLANTA (Oct. 28, 2016) - Acella Pharmaceuticals, LLC, a specialty pharmaceutical company, recently secured approval for a sugar-free bioequivale..

TEST-right

Contact Us

Please fill out the form below.

678.325.5189

11675 Great Oaks Way, Suite 144
Alpharetta, GA 30022
Privacy Policy | Terms & Conditions
© 2016 Acella Pharmaceuticals, LLC
Site forged by Liquid Anvil